Perrigo CEO Discusses F2Q2013 Results – Earnings Call Transcript

Perrigo CEO Discusses F2Q2013 Results - Earnings Call Transcript However, we are lowering our chance to wait for the launch of several new partners,...


Perrigo CEO Discusses F2Q2013 Results – Earnings Call Transcript
However, we are lowering our chance to wait for the launch of several new partners, including the wider (inaudible) family of products and Loratadine D-12 (ph). Due to the limited visibility we have … on the launches of these partner products
Read on
more

Leave a Reply